Nanfang Hospital of Southern Medical University — Guangzhou

Public research footprint of Nanfang Hospital of Southern Medical University, compiled from the ClinicalTrials.gov public registry.

224

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung (NSCLC) · MSI-H/dMMR Solid Tumors · Subacute Cutaneous Lupus Erythematosus

Recently updated registry entries

NCT07218341 — A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… (Recruiting)
NCT06097260 — Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for… (Terminated)
NCT07729839 — Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Nanfang Hospital of Southern Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.